Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Mark L Pacala

Director at Oncology Institute, Inc. (STLN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $200K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 20SEC STLNOncology Institute, Inc. Sell 2,160222,811 held (−1%) $4.00 $9K +60.7%
Nov 20SEC STLNOncology Institute, Inc. Sell 1,210221,601 held (−1%) $4.00 $5K +60.7%
Nov 20SEC STLNOncology Institute, Inc. Sell 46,630174,971 held (−21%) $4.00 $187K +60.7%